Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

HPV infection and pre-neoplastic cervical lesions among 321 HIV+ women in Florence, Italy, 2006-2016: prevalence and associated factors.

Fusco FM, Vichi F, Bisanzi S, Sani C, Degli Esposti A, Blè C, Rossi R, Pompeo G, Carozzi F, Blanc P.

New Microbiol. 2018 Sep 25;41(4). [Epub ahead of print]

2.

Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.

Carozzi FM, Bisanzi S, Carrozzi L, Falaschi F, Lopes Pegna A, Mascalchi M, Picozzi G, Peluso M, Sani C, Greco L, Ocello C, Paci E; ITALUNG Working Group.

Int J Cancer. 2017 Jul 1;141(1):94-101. doi: 10.1002/ijc.30727. Epub 2017 Apr 21.

3.

Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.

Giorgi Rossi P, Bisanzi S, Allia E, Mongia A, Carozzi F, Gillio-Tos A, De Marco L, Ronco G, Gustinucci D, Del Mistro A, Frayle H, Iossa A, Fantacci G, Pompeo G, Cesarini E, Bulletti S, Passamonti B, Rizzi M, Penon MG, Barca A, Benevolo M.

J Clin Microbiol. 2017 Apr;55(4):1056-1065. doi: 10.1128/JCM.01794-16. Epub 2017 Jan 18.

4.

[HPV primary test in the cervical cancer screening: reproducibility assessment and investigation on cytological outcome of Hybrid Capture 2 borderline samples].

Burroni E, Sani C, Bisanzi S, Ocello C.

Epidemiol Prev. 2016 Mar-Apr;40(3-4):164-70. doi: 10.19191/EP16.3-4.AD03.077. Italian.

5.

[Molecular biomarkers and early diagnosis of lung cancer: state of knowledge and future perspectives].

Carozzi FM, Bisanzi S.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):56-63. doi: 10.19191/EP16.1S1.P056.031. Italian.

6.

Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?

Carozzi F, Tamburrino L, Bisanzi S, Marchiani S, Paglierani M, Di Lollo S, Crocetti E, Buzzoni C, Burroni E, Greco L, Baldi E, Sani C.

J Cancer Res Clin Oncol. 2016 Jan;142(1):201-12. doi: 10.1007/s00432-015-2015-1. Epub 2015 Jul 26.

PMID:
26210155
7.

Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.

Burroni E, Bisanzi S, Sani C, Puliti D, Carozzi F.

J Med Virol. 2013 Jan;85(1):83-90. doi: 10.1002/jmv.23417. Epub 2012 Nov 4.

PMID:
23124863
8.

Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

Carozzi FM, Burroni E, Bisanzi S, Puliti D, Confortini M, Giorgi Rossi P, Sani C, Scalisi A, Chini F.

J Clin Microbiol. 2011 Apr;49(4):1446-51. doi: 10.1128/JCM.02311-10. Epub 2011 Feb 16.

9.

Distribution of high and low risk HPV types by cytological status: a population based study from Italy.

Giorgi Rossi P, Chini F, Bisanzi S, Burroni E, Carillo G, Lattanzi A, Angeloni C, Scalisi A, Macis R, Pini MT, Capparucci P, Guasticchi G, Carozzi FM; Prevalence Italian Working Group.HPV.

Infect Agent Cancer. 2011 Jan 20;6:2. doi: 10.1186/1750-9378-6-2.

10.

Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.

Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E, Costantini AS, Gorini G.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):52-8. doi: 10.1016/j.ijrobp.2010.04.023. Epub 2010 Aug 12.

PMID:
20708344
11.

Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.

Giorgi Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, Macis R, Pini MT, Chini F, Carozzi FM; HPV Prevalence Italian Working Group.

BMC Infect Dis. 2010 Jul 20;10:214. doi: 10.1186/1471-2334-10-214.

12.

Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis.

Carozzi FM, Bisanzi S, Falini P, Sani C, Venturini G, Lopes Pegna A, Bianchi R, Ronchi C, Picozzi G, Mascalchi M, Carrozzi L, Baliva F, Pistelli F, Tavanti L, Falaschi F, Grazzini M, Innocenti F, Paci E; ITALUNG Study Research group.

Lung Cancer. 2010 May;68(2):216-21. doi: 10.1016/j.lungcan.2009.06.015. Epub 2009 Jul 30.

PMID:
19646775
13.
14.

Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytology.

Maddau C, Confortini M, Bisanzi S, Janni A, Montinaro F, Paci E, Pontenani G, Rulli P, Salani A, Zappa M, Benvenuti A, Carozzi FM.

Am J Clin Pathol. 2006 Mar;125(3):425-31.

PMID:
16613347
15.

Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies.

Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, Pontenani G, Ciatto S.

Int J Biol Markers. 2004 Oct-Dec;19(4):257-61.

PMID:
15646830
16.

Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment.

Carozzi FM, Confortini M, Cecchini S, Bisanzi S, Cariaggi MP, Pontenani G, Raspollini MR, Sani C, Zappa M, Ciatto S.

Cancer. 2005 Feb 25;105(1):2-7.

17.

Genetic analysis in nine unrelated Italian patients affected by OTC deficiency: detection of novel mutations in the OTC gene.

Bisanzi S, Morrone A, Donati MA, Pasquini E, Spada M, Strisciuglio P, Parenti G, Parini R, Papadia F, Zammarchi E.

Mol Genet Metab. 2002 Jun;76(2):137-44.

PMID:
12083811

Supplemental Content

Loading ...
Support Center